Cipla | Zee News

Advertisement

Cipla News

Independence Day

09 Aug 2022

7 Indian MNC born before Independence making India proud around globe

Tata Group was established by Jamsetji Nusserwanji Tata in 1968. Ghanshyam Das Birla laid the foundation of Aditya Birla Group in 1911 as an Industrialist company in Pilani (Rajasthan). Dabur was established by Dr. S.K Burman in 1884 in Calcutta to make health care products.

15 Feb 2022

Cipla promoters sell shares worth over Rs 1,835 crore

After this transaction, the promoter group will continue to hold 34.23 per cent in the company, it added. The promoter group does not plan to sell any further shares in the foreseeable future, the filing further said.

29 Jun 2021

5 Indian pharma companies would jointly conduct a clinical trial of COVID drug

Molnupiravir is an antiviral therapy Merck is developing with Ridgeback Biotherapeutics for the treatment of non-hospitalized COVID-19 patients

29 Jun 2021

Vaccine no. 4 is almost here, Cipla gets nod to import Moderna jab

Cipla on Monday sought the DCGI’s nod for importing the Moderna’s vaccine and submitted an application

16 Jun 2021

Scrutinise roles of MLA Zeeshan, Sonu Sood in getting anti-COVID drugs: HC

The high court also observed that "these people (celebrities) projected themselves as some kind of messiahs without verifying if the drugs were spurious or if the supply was legal".

antibody therapy

28 May 2021

What is an antibody cocktail, is it effective against COVID-19, Zee explains

The antibody therapy is a cocktail of two monoclonal antibodies - Casirivimab-Imdevimab injection The therapy is most suited for "high-risk COVID-19 patients" who are within the first ten days of symptom onset Switzerland-based Roche has developed this antibody cocktail and launched it in the Indian market along with Cipla

26 May 2021

Moderna to launch single-dose COVID-19 vaccine in India likely next year

Moderna will launch a single-dose COVID-19 vaccine in India next year Meanwhile, Pfizer is ready to offer 5 crore doses this year

24 May 2021

Roche, Cipla launch Antibody Cocktail for treatment of mild to moderate COVID

Roche, Cipla launch ‘Antibody Cocktail’ for COVID treatment The drug can be used to treat patients suffering mild to moderate symptoms The drug is priced at Rs 59,750 per dose

04 Aug 2020

Cipla witnesses 3 senior-level exits including India biz CEO

Chopra joined the company in 1996 and has served in various leadership positions across India. The other two executives are Nikhil Lalwani, head of India prescription business, and Kunal Khanna, cluster head of chronic and emerging business development and portfolio. The company, however, did not share the reasons for the exits.

22 Jun 2020

Glenmark, Cipla stocks surge after nod to launch drugs for COVID-19

The Nifty pharma index was trading higher by 2.62 percent at 10264.45 at 2.41 pm.

BSE's benchmark index

17 Nov 2017

IndusInd Bank, Yes Bank to join BSE Sensex; Cipla, Lupin exit

The changes are announced by Asia Index, a joint venture between S&P Dow Jones Indices LLC and BSE. The move is a part of Asia Index's semi-annual reconstitution results.

04 Aug 2017

Indian equities trade flat with marginal losses, healthcare stocks slip

On Thursday, weak services sector data and heavy selling pressure in banking and metal stocks dragged the benchmark indices lower.

16 Jun 2017

Cancer drug: SC allows Cipla to withdraw appeal against Roche

The Supreme Court on Friday allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer drug, to withdraw its petition on the patent row.

Investore wealth

26 May 2017

Investor wealth surges over Rs 50 lakh crore in 3 years

Investor wealth has surged by over Rs 50 lakh crore since the Modi government was voted to power three years ago, with the Sensex surging to its lifetime high of 31,074.07 on Friday.

26 May 2017

Cipla shares down 3%; mcap dips Rs 1,003 crore post Q4 results

Shares of pharma major Cipla on Friday fell by 3 percent after the company reported a consolidated net loss of Rs 61.79 crore for the March quarter.

04 Apr 2017

Cipla gets USFDA nod for generic HIV drug

Cipla has received approval from the US health regulator for its generic Abacavir and Lamivudine tablets used for treatment of HIV infection.

23 Feb 2017

634 drugs on NPPA's price ceiling non-compliant list

As many as 634 drugs of various strengths produced by firms, including Cipla, Abbott, Astrazeneca and Dr Reddy's, are "suspected" to be non-compliant with ceiling prices as notified by NPPA.

19 Jan 2017

Cipla initiates campaign for a pollution free Delhi; starts #saveyourlungsdilli

According to a TGI Survey, 34 percent (approx five million) of Delhi people are suffering respiratory problems including Asthma, Bronchitis, and Chronic Obstructive Pulmonary Disease.

29 Nov 2016

Cipla appoints Ireena Vittal as independent director

Drug major Cipla on Tuesday said it has appointed Ireena Vittal as an independent director on its board with effect from December 1, 2016.

30 Sep 2016

Cipla gets four USFDA observations for three Goa facilities; stocks fall over 3%

Drug firm Cipla on Friday said the US health regulator has issued four observations across its three manufacturing facilities in Goa after the inspection.

Loading...

NEWS ON ONE CLICK